Amarin Corporation PLC reports results for the quarter ended June 30 - Earnings Summary

Amarin

30/07/2025 14:32

Amarin Corporation PLC AMRN.OQ reported quarterly adjusted earnings of 42 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported breakeven earnings per share.  The mean expectation of three analysts for the quarter was for a loss of 18 cents per share. Wall Street expected results to range from -60 cents to 43 cents per share.

Revenue rose 7.8% to $72.74 million from a year ago; analysts expected $53.76 million.

Amarin Corporation PLC's reported EPS for the quarter was a loss of 68 cents​.

The company reported a quarterly loss of $14.14 million.

Amarin Corporation PLC shares had fallen by 9.7% this quarter and gained 51.0% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 73.2% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "sell" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is  "buy."

Wall Street's median 12-month price target for Amarin Corporation PLC is $16.00, about 8.4% above its last closing price of $14.65

This summary was machine generated from LSEG data July 30 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-0.18
0.42
Beat
Mar. 31 2025
-0.57
-0.76
Missed
Dec. 31 2024
-1.07
-0.60
Beat
Sep. 30 2024
-1.00
-1.20
Missed